The pituitary gland constitutes, together with the hypothalamus, the regulatory core of the endocrine system. Whether the gland is capable of cell regeneration after injury, in particular when suffered at adult age, is unknown. To investigate the adult pituitary's regenerative capacity and the response of its stem/progenitor cell compartment to damage, we constructed a transgenic mouse model to conditionally destroy pituitary cells. GHCre/iDTR mice express diphtheria toxin (DT) receptor after transcriptional activation by Cre recombinase, which is driven by the GH promoter. T he pituitary gland is the core endocrine organ that, together with the hypothalamus, governs the hormone balances in the body. The gland contains multiple hormone-producing cell types that noticeably remodel in answer to changing endocrine demands of the organism. Before, it has repeatedly been proposed that stem cells contribute to these plastic cell adaptations (reviewed in Ref. 1). However, the stem cells of the pituitary remained elusive and were only very recently identified (reviewed in Ref.
The pituitary gland constitutes, together with the hypothalamus, the regulatory core of the endocrine system. Whether the gland is capable of cell regeneration after injury, in particular when suffered at adult age, is unknown. To investigate the adult pituitary's regenerative capacity and the response of its stem/progenitor cell compartment to damage, we constructed a transgenic mouse model to conditionally destroy pituitary cells. GHCre/iDTR mice express diphtheria toxin (DT) receptor after transcriptional activation by Cre recombinase, which is driven by the GH promoter. T he pituitary gland is the core endocrine organ that, together with the hypothalamus, governs the hormone balances in the body. The gland contains multiple hormone-producing cell types that noticeably remodel in answer to changing endocrine demands of the organism. Before, it has repeatedly been proposed that stem cells contribute to these plastic cell adaptations (reviewed in Ref. 1) . However, the stem cells of the pituitary remained elusive and were only very recently identified (reviewed in Ref. 2) . Our group tracked down the stem/progenitor cells of the endocrine anterior pituitary (AP) lobe in the nonSca1 (stem cell antigen- 1) high subset of the Hoechst dye-effluxing side population (SP) (3, 4) , for simplicity further referred to as the stem cell-SP (SC-SP). The stem/progenitor cells were found to express Sox2 (4, 5) , a transcription factor with a cardinal role in a variety of stem cells (6) . Sox2 ϩ cells were localized in the marginal zone around the cleft (4, 5, 7, 8) , which is a remnant of Rathke's pouch, the embryonic anlage of the pituitary's AP and intermediate lobe. This zone has recurrently been postulated to embody the stem cell niche in the pituitary (reviewed in Refs. 1, 2, and 9). In addition, clusters of Sox2 ϩ cells were found scattered over the anterior lobe parenchyma (4, 5, 7, 10) , suggestive of multiple niches (9) . In various adult organs, stem cells play a significant role in tissue repair after injury (1, (11) (12) (13) . Whether the pituitary gland is capable of cell regeneration after loss by damage when occurring at adult age is at present not clear. Borrelli et al. (14) observed reappearance of somatotropes after destruction using the herpes simplex virus 1-thymidine kinase obliteration system. However, because this approach kills only dividing cells, treatment was performed in embryonic and early postnatal life to ablate the developing GH-expressing cells. Cell obliteration was not done, and regeneration not studied, in the gland at adult age when the preponderance of hormonal cells is postmitotic. Only very few studies addressed the question of regenerative capacity of the mature pituitary (15, 16) . Moreover, opposing conclusions were reported; some restoration was observed after electrocoagulation of pituitary tissue in human cancer patients, but no regeneration was found in adult rats after partial hypophysectomy. Both studies, however, detected some activation of chromophobes, cells at that time assumed to present pituitary stem cells (1) .
To finally advance the issue on the regenerative capacity of the pituitary at adult age, we set up a transgenic injury model in which pituitary cells, whether dividing or not, can be destroyed in a conditional manner using the diphtheria toxin (DT)/inducible DT-receptor (iDTR) system (17) . In the GHCre/iDTR model used, Cre expression is driven by the (rat) GH promoter (18) leading to excision of a STOP cassette, thus allowing DTR expression and cell destruction by DT. We show that pituitary stem/progenitor cells acutely react to the damage inflicted at adult age and that ablated GH ϩ cells are, at least partially, restored.
We provide evidence that supports a role for stem/progenitor cells in this regeneration process.
Materials and Methods

Transgenic mice and genotyping
iDTR mice harbor the simian DTR gene in the ROSA26 locus (17) . Transcription is blocked by an upstream STOP cassette flanked by LoxP sites. When bred to Cre-expressing mice, the STOP sequence is excised in the cells where Cre recombinase is expressed, thus permitting DTR expression, which renders these cells susceptible to destruction by DT. Homozygous iDTR/iDTR mice were crossed to hemizygous GHCre/Ϫ mice (18) , expressing Cre under control of the rat GH promoter. Offspring were genotyped for the presence of the Cre transgene by PCR using 5Ј-TGCCACGACCAAGTGACAGCAATG-3Ј and 5Ј-ACCA-GAGACGGAAATCCATCGCTC-3Ј as primers.
Mice were bred on a C57BL6 genetic background and kept in the Animal Housing Facility of the Katholieke Universiteit Leuven with constant temperature, humidity and day/night cycle, and free access to water and food. Animal experiments were approved by the Ethical Committee of the University.
Treatment of mice with DT and 5-ethynyl-2-deoxyuridine (EdU)
Adult (8 to 12 wk old) double-transgenic GHCre/Ϫ;iDTR/Ϫ mice (hemizygous for both transgenes, further referred to as GHCre/iDTR) and Cre-negative mice from the same litters (controls, referred to as Ϫ/iDTR) were ip injected with DT (from Corynebacterium diphtheria; Sigma-Aldrich, Bornem, Belgium) or vehicle (PBS; Invitrogen, Grand Island, NY). First, different doses and time schedules were tested to obtain a nontoxic regimen with maximal ablation (data not shown). Multiple ip injections were chosen because such a regimen most effectively ablates cells in other tissues (17) . Eventually, a DT treatment regimen of 4 ng DT/g body weight, twice a day with 8-h intervals for 3 d, was defined (see Fig. 1A ). Typically, three to six mice were grouped per condition in the independent experiments. Preceding control experiments demonstrated that expression of DTR or Cre per se does not cause any distinguishable pituitary phenotype and that DT treatment does not affect proportions of hormone cell populations in the absence of Cre expression (in Ϫ/iDTR and iDTR/ iDTR mice) (data not shown).
To detect dividing (DNA-synthesizing) cells, mice were ip injected with EdU (Invitrogen) at 100 g/g body weight, and pituitaries were analyzed, both according to the schedules as depicted in the different figures.
Isolation of AP cells
Mice were euthanized by exposure to CO 2 and the neurointermediate lobe of the pituitary discarded. The AP lobe was dissociated into single cells as described before (3, 4) , and cells were resuspended in pituitary-optimized serum-free defined medium (SFDM; Invitrogen) (3, 4) .
Immunofluorescence and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analysis of dissociated AP cells
Cytospin preparations of dispersed AP cells were fixed with paraformaldehyde (4% in PBS), permeabilized with saponin (Sigma-Aldrich; 0.5% in PBS), and incubated overnight with rabbit antimouse GH (1/10,000), antirat prolactin (PRL) (1/ 10,000), antirat ACTH (1/5000); and/or guinea-pig antirat GH (1/5000), antirat PRL (1/2500), and antirat ␣-glycoprotein subunit (␣GSU) (1/1000 Uptake of the dipeptide ␤-Ala-Lys-N⑀-7-amino-4-methylcoumarin-3-acetic acid (AMCA) was used as a marker for folliculostellate (FS) cells (19) . Dispersed cells were seeded on poly-L-lysine-coated Lab-Tek chamber slides (Thermo Scientific) in SFDM. AMCA (Biotrend, Zurich, Switzerland) was added to the culture at a concentration of 40 M, and cells were incubated for 2 h at 37 C. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.4% Triton X-100 (Sigma-Aldrich). To visualize AMCA uptake together with Sox2 and Ki67 expression, cells were further incubated with primary antibodies and processed as described above. Pictures were captured, and proportions and absolute numbers determined as above.
Apoptosis was scored by TUNEL analysis in cytospin preparations of fixed AP cells using the FragEL kit (Calbiochem, Darmstadt, Germany) according to the manufacturer's protocol. Subsequently, GH and PRL immunostaining was performed as described above, and apoptotic cells within the respective cell populations counted.
Immunofluorescence examination of pituitary vibratome sections
Whole pituitaries were isolated, fixed in 4% paraformaldehyde, embedded in 2% agarose (MP Biomedicals, Aurora, OH), and coronally sectioned to 45-m slices using a vibratome (Microm HM 650V; Prosan, Merelbeke, Belgium), all as described before (3, 4, 19) . After permeabilization with 0.4% Triton X-100, sections were incubated overnight with rabbit anti-Sox2 (1/200; Millipore, Brussels, Belgium) or goat anti-Sox2 antibodies (1/250 -1/750; Immune Systems). To simultaneously detect Sox2, hormones, Ki67, and/or cleaved caspase 3 (CC3), the appropriate antibodies were added together, followed by incubation with labeled secondary antisera (see above; rabbit anti-CC3 from Cell Signaling, Danvers, MA). In the pulse-chase experiments, EdU was subsequently detected in the sections as described above. Finally, ToPro-3 was added to label the nuclei (0.01 mM; Invitrogen), and slices were mounted in Vectashield (Vector Laboratories, Burlingame, CA) and scanned using a confocal laser scanning microscope (Zeiss LSM 510; Zeiss, Zaventem, Belgium). Images were prepared with Zeiss LSM Image Browser and assembled with Microsoft PowerPoint (2007).
SP analysis
The pituitary SP was analyzed as described in detail before (3, 4) . In brief, AP cells were incubated with Hoechst33342 (SigmaAldrich), stained with phycoerythrin (PE)-conjugated rat antimouse Sca1 (BD Biosciences, San Jose, CA), and examined using dual-wavelength flow cytometry (FACSVantage; BD Biosciences). Control experiments were performed with verapamil, which blocks the SP's dye efflux (3, 4) (data not shown).
Pituisphere assay
Sphere-forming capacity was studied as reported (3, 4) . Briefly, dissociated AP cells were seeded in SFDM supplemented with basic fibroblast growth factor and B27 (Invitrogen), and the developed spheres were enumerated 7 d later.
Statistical analysis
One-way ANOVA was applied to all experiments and performed using SPSS software (Version 13.0; IBM, Brussels, Belgium). Degrees of freedom equals 1 for comparison of 2 groups, and equals 2 for comparison of 3 groups. In the latter case, ANOVA was followed by Least Significant Difference (LSD) Post Hoc Multiple Comparison. Statistical significance was defined as P Ͻ 0.05. Exact P-values, together with F-values, are given in Supplemental Table 1 .
Results
Treatment of GHCre/iDTR mice with DT induces cell-ablation injury in the pituitary
Adult GHCre/iDTR and control (Ϫ/iDTR) mice were injected ip with DT for 3 consecutive days, and pituitaries were analyzed 1 d later (d 4) and 1 wk later (d 11) (see Fig.  1A ). In situ examination shows that GH-immunoreactive (GH ϩ ) cells (somatotropes) gradually decline in the pituitary of the GHCre/iDTR mice (Fig. 1B) (Fig. 1C) . The decline is halted at d 11, consistent with the return of GH ϩ cell apoptosis to basal levels, indicating that all DT-sensitive somatotropes have been destroyed by that time ( Fig. 1D ; apoptosis by TUNEL analysis). Ablation grade eventually reaches 80 -90%, which is comparable to DT-induced cell-destruction efficiency in other tissues (17, 20 -22 (Fig. 1E) . Possible reasons for the decline in lactotropes are given in the Discussion. All analyses described above were performed separately for male and female mice, but no significant differences were detected between the sexes (Supplemental Fig.  1B) , and experiments below were performed with mixed genders. Despite the cell killing in the AP, inflammatory cell infiltration is not observed (data not shown), in accordance with previous studies using DT-mediated cell ablation by apoptosis (17, 20 -23) and in contrast to cell destruction by necrotic mechanisms (24) .
It should be noted that we recently used the somatotrope ablation model to cause adult-onset GH deficiency and study the impact of reducing GH levels on metabolic function (25) . In that report, DT was continuously infused at a low dose by osmotic minipump (for 7 d), which was effective in reducing pituitary GH mRNA levels and circulating GH levels to 20 -50% of controls (without altering circulating PRL levels). Detailed analysis of the pituitary phenotype over the early course of somatotrope destruction was not performed. Here, we chose to apply multiple ip injections of a higher dose of DT to ensure maximum destruction of somatotropes (17) . Therefore, information regarding the (pituitary) phenotype in the previous study (25) cannot be used in, or directly compared with, the current report.
In conclusion of this part, we designed a transgenic mouse model in which pituitary cells can be conditionally destroyed, thus providing a platform to study stem/progenitor cell behavior and the adult gland's regenerative capacity in response to injury.
The pituitary stem/progenitor cell-clustering SP expands after injury
To examine whether pituitary stem/progenitor cells react to damage in the adult gland, we first compared the SP (3, 4) between DT-treated GHCre/iDTR and control mice. The SP compartment promptly expands after DT-induced injury (d 4; Fig. 2, A and B) . Moreover, the stem/progenitor cell-clustering subset of the SP, the SC-SP (4), is significantly enlarged (Fig. 2, A and C) . Also in other tissues, the SP, being enriched in the resident stem cells, expands in answer to experimentally inflicted damage (26, 27) .
The pituitary Sox2
؉ stem/progenitor cell compartment displays an activated phenotype in response to injury Sox2 is highly expressed in the pituitary SC-SP (4) (Fig. 3A, i , iv, and v; Supplemental Video 1). Sox2 ϩ cells of the wedge region appear to sprout toward the lobes, which is also found, although less blatantly, in control mice (Supplemental Video 2). These observations suggest a bud-like nature of this specific area and further support our recent findings during neonatal maturation of the gland (10). After DT-induced injury, also the Sox2 ϩ cells within the submarginal zone (Fig. 3A , ii and iii) and the ones more distal in the gland's parenchyma (Supplemental Fig. 2A ) are more copious in GHCre/iDTR than control mice. As observed before (4, 10) , the Sox2 ϩ cell compartment does not only include cells with Sox2 in the nucleus, as expected for a transcription factor, but also some cells with Sox2-immunoreactive signal in the cytoplasm (28) . These Sox2-cytoplasmic cells are also more numerous in the DTtreated GHCre/iDTR mice ( Fig. 3A and Supplemental Fig. 2A) . Noteworthy, some of these Sox2-cytoplasmic cells are small and are found only in the GHCre/iDTR but not the control gland (arrows in Fig. 3A , iii, and in Supplemental Fig. 2A, ii and iii) . To validate the more abundant in situ appearance of Sox2 ϩ cells in GHCre/iDTR pituitary after DT-provoked injury, we counted the Sox2 ϩ cells after AP cell dispersion,
revealing an approximately 2-fold rise at d 4 (Fig. 3B) . The increase in stem/progenitor cells was further validated by analyzing the formation of spheres in culture (3) (4) (5) . After DT treatment, 2.3-fold (Ϯ0.2, n ϭ 5; P Ͻ 0.01) more pituispheres were obtained from AP cells of GHCre/iDTR mice, consistent with the rise in SC-SP and Sox2 ϩ cells.
We examined several mechanisms of expansion of the Sox2 ϩ stem/progenitor cell compartment in response to the cell-ablation injury. First, proliferative activity was analyzed by Ki67 immunostaining after 1 and 3 d of DT injection (see Fig. 3C ). Whereas Ki67 is practically not observed in Sox2 ϩ cells of the control pituitary, it is promptly and readily detected in these cells after DT-induced injury (Fig. 3, C and D) . Double Ki67 ϩ /Sox2 ϩ cells are found both in the marginal layer including the wedge area ( Fig. 3C and Supplemental Video 3) and in the AP lobe's parenchyma (Supplemental Fig. 2B ). These results were confirmed using labeling of dividing (DNA-synthesizing) cells with EdU (see Supplemental Fig. 2C ). Second, we examined whether Sox2 ϩ cells increase in abundance because they become more robust and undergo less apoptosis after the gland is injured. However, apoptosis (as analyzed by expression of CC3) was not observed in the Sox2 ϩ cells, neither in control nor in GHCre/iDTR mice (Supplemental Fig.  3 ). Third, we looked at the reaction of the FS cells in relation to the Sox2 (Fig. 4A and data not shown) . Interestingly, the fraction within the Sox2 ϩ cell population that is labeled with AMCA decreases (Fig. 4D) . Taken all together, our data suggest several mechanisms of Sox2 ϩ cell expansion showing a prompt expansion that is most prominent at the wedge regions.
The pituitary gland is capable of repairing injury that is suffered at adult age
To explore the still unsettled regenerative capacity of the pituitary, in particular when damage is suffered at adult age, mice were treated with DT for 3 d and hormone-immunoreactive cell numbers determined at final ablation (d 11) and 4 -5 months later (see Fig. 5 ). Interestingly, differences in GH ϩ cell number between GHCre/iDTR and control mice become smaller after this lag period (Fig. 5A ). This indication that somatotropes are, at least partially, restored is convincingly supported by in situ immunoanalysis ( (Fig. 1, B and C).
Stem/progenitor cells appear involved in the regeneration of the ablated GH ؉ cells
To investigate the involvement of stem/progenitor cells in the somatotrope regeneration, we analyzed the Sox2 ϩ cell compartment for expression of GH. Remarkably, promptly after start of DT-induced injury (d 3 and 4), GH is found in Sox2 ϩ cells in the GHCre/iDTR mice and more particularly in the small Sox2-cytoplasmic cells that are not present in the control mice ( Fig. 6A and Supplemental Fig. 5A ). The double Sox2 ϩ /GH ϩ cells are present both in the submarginal zone ( Fig. 6A and Supplemental Fig. 5A ) and in the AP lobe parenchyma (Supplemental Fig. 5A , iii-v). These observations suggest that stem/progenitor cells promptly attempt to counteract the somatotrope damage by differentiating to GH-expressing cells. However, acute restoration is not effective, and GH ϩ cells continue to decline In agreement, gradual restoration of the GH ϩ cells is observed at these time points (Supplemental Fig. 6B ). Moreover, the absolute number of Sox2 ϩ cells after 5 months is still 1.5-fold (Ϯ0.6; n ϭ 3) higher in GHCre/iDTR than control mice. Of note, Sox2 ϩ cell abundance in normal (control) mice decreases during aging from approximately 12% in 2-to 3-month-old mice (Fig.  3B ) to 6.9% (Ϯ0.5; n ϭ 3; P Ͻ 0.05) at an older age (7-8 months) . In further support of the participation of stem/ progenitor cells in GH ϩ cell regeneration is the absence of small Sox2-cytoplasmic cells that express PRL (Supplemental Fig. 5B ), which corresponds to the lack of lactotrope restoration (Fig. 5A) . Immunoreactive signals for PRL as well as the other hormones are sometimes found in larger Sox2-cytoplasmic cells, but these double-immunoreactive cells are not frequent and not visibly different from control pituitaries (Supplemental Fig.  5B ), supporting our previous hypothesis that they may represent normal turnover events in the slowly renewing adult gland (2, 4, 9, 10).
Another possible mechanism of somatotrope regeneration is through proliferation of surviving GH (Fig. 7C) 
Discussion
In the present study, we constructed an inducible cell-ablation model to explore stem/progenitor cell behavior and regenerative capacity of the pituitary in response to injury when inflicted at an adult age. A prompt and clear-cut reaction of the stem/progenitor cell compartment was observed, as evidenced by expansion of the SC-SP, of the pituisphere-forming cells, and of the Sox2 In the months that follow the ablation, somatotropes are being regenerated. This regeneration may be driven by several mechanisms including transdifferentiation of lactotropes (1, 29) or of other hormonal cell types (30) , proliferation of surviving somatotropes, and/or recruitment from stem/progenitor cells. Transdifferentiation does not seem to play a significant role because transitional bihormonal cells (with GH) are not present or do not augment after cell-ablation injury. Rescue by GH ϩ cell proliferation is also no major mechanism because dividing GH ϩ cells are virtually nonexistent in the transgenically injured pituitary. At the same time, the latter observation suggests that hypothalamic factors like GHRH are not involved through a proliferative activity on the remaining somatotropes (32 including 1) the presence of restoration-inhibiting influences (34), 2) a still longer recovery time required, 3) no organismal need for full restoration to attain satisfactory GH functions, 4) different regeneration degrees with different types of injury (as found in pancreas and lung) (22, 35) , 5) or waning of full repair capacity when the tissue becomes mature (vs. higher regenerative capacity at embryonic age) (34, 36, 37) . Unraveling the underlying mechanisms of repair may identify molecular pathways to harness for better restoration (31) . Besides the transgenically targeted somatotropes, PRLimmunoreactive cells are also reduced in our GHCre/ iDTR model. A possible cause is low-level expression of DTR in certain lactotropes. Transgenic GH promoter activity has indeed been observed in some (ϳ10%) lactotropes of the GHCre mouse (18) . DT is highly effective (38) , and low-level expression of DTR may be sufficient to kill the cells although in a tardy fashion because apoptotic lactotropes do not occur yet at d 4 after injection. Alternatively, the delayed effect on lactotropes may be due to an indirect rather than direct impact. Lactotropes may need paracrine signals from somatotropes to survive (32) . Also, given the recurrently postulated descent of (subsets of) lactotropes from somatotropes (1, 14, 29) , destruction of somatotrope cells may jeopardize lactotrope cell formation, and/or lactotropes that are formed from somatotropes could express DTR and thus be killed. However, the turnover rate of lactotropes from somatotropes must then be very high because substantial lactotrope decline is observed in terms of days (i.e. between d 4 and 11). To our knowledge, such intense developmental transition of somatotropes to lactotropes has not been reported. What is more, substantial descent of PRL ϩ cells from GH ϩ cells has recently been questioned (18) , here also supported by the virtual absence of double PRL ϩ /GH ϩ cells both in control and injured pituitary. Of note, no significant impact was observed on PRL levels and on functional endpoints of the PRL axis (such as pregnancy and lactation) using the ablation model in our recent study (25) . One possible explanation is that DT was delivered at a low constant dose using osmotic minipumps, whereas here multiple injections of higher doses were used for maximal somatotrope ablation. Finally, PRL ϩ cells do not recover in our model, which requires further investigation.
In conclusion, our study shows that the pituitary gland is competent to repair tissue after cell loss by injury occurring at an adult age. Stem/progenitor cells are likely involved given their remarkable reaction including expansion and GH coexpression. Further deciphering the regenerative process using this pituitary lesion model is expected to expose pathways valuable for future clinical translation.
